[The Efficiency of Gene Activation Using CRISPR/dCas9-Based Transactivation Systems Depends on the System Run Time]

A S Artyuhov1, D A Dorovskiy2, A V Sorokina1

  • 1Center of Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, 117997 Russia.

Molekuliarnaia Biologiia
|December 7, 2022
PubMed
Summary

CRISPR/Cas9 transactivation systems offer gene control in cell culture, but performance varies. This study compared three systems (dCas9-VP160, dCas9-SunTag, dCas9-VPR) in human fibroblasts, finding efficiency depended on the system and duration.